Protara Therapeutics, Inc. - TARA Operating profit EBITDA
Operating cash flow before interest and taxes exhibits volatility, as the implementation of laboratory robots for molecule screening has not yet stabilized profits. The 0.00 metric indicates a liquidity status that depends on venture capital and the non-cyclical nature of drug development. Meanwhile, outsourcing production to contract organizations allows Protara Therapeutics (TARA) to optimize logistics when treating rare forms of cancer.
Summary analytical data breakdowns for Protara Therapeutics, Inc. (TARA)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
Aggregate Debt to Equity Protara Therapeutics|TARA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Protara Therapeutics Inc|TARA - Company Debts|Debts to Book Value Protara Therapeutics|TARA - Company Long-Term Liabilities|Amount of Current Liabilities Protara Therapeutics|Quick Ratio protaratx.com
- earnings and market ratios statistics:
TARA - Company Net Income|Expected Net Income Protara Therapeutics|TARA - P/E Multiple|Forward P/E Multiple protaratx.com|TARA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Protara Therapeutics|TARA - Operating profit before deduction of amortization|Earnings per share for the last four quarters Protara Therapeutics|TARA - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months protaratx.com|TARA - Earnings growth in current year|Expected net earnings per share growth next year Protara Therapeutics
Analysis of all company metrics:Protara Therapeutics
This indicator tracks daily operational cash flow, allowing investors to filter out market noise and determine the true trajectory of business development. By analyzing the current EBITDA on the GURU.Markets platform, one can assess the financial stability of Protara Therapeutics (TARA) during a period of costly oncology tests and plastic environmental disposal expenses, which is critical for minimizing the risk of purchasing the asset at its peak.
Competitor analysis for Protara Therapeutics
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Delcath Systems DCTH|Income before deduction of interest, taxes and amortization YMAB|AURA - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Candel Therapeutics|ARAY (Accuray Incorporated) - Operating profit before deduction of amortization|SLS: Company profit before taxes, interest and amortization|ACTU (Actuate Therapeutics) - Operating profit EBITDA|Operating profit EBITDA Citius Oncology Inc.|Profit before payment of interest, taxes and amortization TuHURA Biosciences, Inc. (HURA)|FATE (Fate Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA WHWK (Aadi Bioscience)|Operating profit EBITDA TScan Therapeutics Inc TCRX|CSBR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization XBIT (XBiotech Inc.)|CVM (cel-sci.com) - Operating profit before deduction of amortization|OSTX: Company profit before taxes, interest and amortization|RADX (Radiopharm Theranostics) - Operating profit EBITDA|ARTV: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANL|VERU - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tempest Tx TPST|Income before deduction of interest, taxes and amortization XLO|Enochian BioSciences - Operating profit EBITDA|MURA - Operating profit EBITDA|kairospharma.com (KAPA) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization OKUR (OnKure Therapeutics)|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Curis Corp CRIS|Operating profit before deduction of amortization APLM (Apollomics, Inc.)|Operating profit EBITDA tharimmune.com (THAR)|Advanced Biomed - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization GNPX (Genprex Inc.)|Calidi Bio - Operating profit EBITDA|Operating income before deduction of amortization sunshinebiopharma.com SBFM|XBIO: Operating profit EBITDA|Operating profit before deduction of amortization salariuspharma.com|Profit before payment of interest, taxes and amortization Purple Biotech Ltd.|AON (AONC) - Operating income before deduction of amortization|Operating profit before deduction of amortization BGNE (BeOne Medicines)|Company profit before taxes, interest and amortization CKPT|Operating profit EBITDA ELEV (Elevation Oncology)|Operating profit EBITDA iCAD Inc. ICAD|IKNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NTBL (Notable Labs Ltd)|VIRX: Operating profit EBITDA|MorphoSys Corporation (MOR) - Operating profit EBITDA|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
